Advances in Nanomaterials-Enabled Immunotherapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 25 November 2025 | Viewed by 35
Special Issue Editor
Interests: 2D materials; nanohybrid and nanoporous naterials; layered double hydroxide; electrocatalyst; CO2 capture and conversion; hydrogen production and fuel cell; biomedical and drug delivery system
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The development of medical drug delivery and bio-imaging systems based on advanced nanomaterials, including nanoparticles as well as nanoporous and nanocomposite materials, has been one of the most crucial challenges to developing personalized medicine via future nanotechnology. Novel immunotherapy research will concentrate on exploring immunotherapeutic function in basic immunology and cancer treatment, as well as medication development enabled by advanced nanomaterials and biomedical research. The potential themes of this Special Issue will cover the significance of advanced nanomaterials, ranging from basic studies to clinical trials in immunotherapy, as well as new scientific developments in the field. This Special Issue is expected to present a unique and up-to-date perspective on immunotherapy and immunotherapeutic function centered around current methods of discovery, emerging nanotechnologies, pre-clinical and clinical trials, and obstacles in the field of nanomaterials.
Dr. Daehwan Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- biomaterials
- immunotherapy
- nanomedicine
- drug delivery system
- cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
